NHS Derby and Derbyshire Clinical Commissioning Group (CCG) policy on ‘Procedures of Limited Clinical Value’ (PLCV).
Research evidence shows that some interventions are not clinically effective or only effective when they are performed in specific circumstances. The purpose of the Procedures of Limited Clinical Value (PLCV) policy is to clarify the commissioning intentions of Clinical Commissioning Group (CCG). The CCG will only fund treatment for clinically effective interventions that are then delivered to the right patients.
This policy lists a number of procedures and services that the CCG restrict funding for out of a fixed budget. Patients should only be referred for the procedures and services listed in this policy if they meet the eligibility set out. If a patient has not had a full diagnosis (relating to PLCV policy areas only), the referring GP is able to refer for an opinion by using the PLCV Opinion Proforma.
The DDCCG agree with the Local Medical Committee's (LMC) following stance on PLCV: ‘GPs are not specialists, we therefore reserve the right to refer by letter to seondary care for an opinion; the specialist having reviewed the patient can decide whether a procedure is necessary and PLCV criteria would apply at this point. A referral for an opinion should not go via prior approval as the request is for an opinion not a procedure’. For further information please click on the following links: https://www.derbyshirelmc.org.uk/position, Derby and Derbyshire CCG PLCV position letter.
Any issues related to this matter should be raised directly with the provider. However, failing this please contact email@example.com
Procedures of Limited Clinical Value policies have been separated into each speciality which are found to the left.
Procedures of Limited Clinical Value that are NOT Routinely Commissioned
(refer to the Cosmetics Policy as appropriate)
|Fat grafts except in post-trauma cases and/or as part of planned reconstruction surgery (e.g. for cancer)|
|Suction assisted lipectomy (liposuction) except as part of planned reconstruction surgery e.g. for cancer or a congenital syndrome|
|Labiaplasty, vaginoplasty, and hymen reconstruction|
|Chin(genioplasty, mentoplasty) /cheek implants except in post trauma cases and/or as part of planned reconstruction following surgery (e.g. for cancer)|
|Cranial banding for positional plagiocephaly|
|Botulinum Toxin – when used to improve cosmetic appearance|
|Resurfacing by laser for skin conditions causing scarring – including post-acne and post-traumatic scarring|
|Correction of nipple inversion (unless part of planned breast reconstruction)|
|Mastopexy (breast uplift) except where criteria are fulfilled|
|Procedures related to gender reassignment not included in the original package of care|
|Hair depilation (removal) for excessive hair growth (hirsutism)|
|Laser treatment for facial hyperpigmentation unless criteria are met|
|Electrolysis treatment for any condition|
|Scar reduction unless it meets criteria|
|ENT||Surgery / Treatment for snoring|
|General Surgery||Anal/rectal skin tags|
|Gynaecology and Fertility|| Reversal of female sterilisation
|Reversal of male sterilisation|
|Imaging||Imaging should not be requested where the result is not expected to alter management|
|Hernias – imaging should not be requested in primary care(see Hernia policy). Refer to a general surgeon where appropriate|
|Low back pain – if referring to a specialist service for management (see policy), imaging requests are not required.|
|Greater Trochanteric Pain Syndrome (GTPS) – see policy for alternative management strategies|
|Morton’s Neuroma – see policy for alternative management strategies|
|Ophthalmology||Laser treatment of myopia|
|Orthopaedics||Autologous Chondrocyte Implantation|
|Knee diagnostic arthroscopy|
|Shoulder resurfacing arthroplasty|
|Therapeutic use of ultrasound in hip and knee osteoarthritis|
|Joint Facet injections|
A Contract Variation (CV) will be issued to providers as and when a policy
is agreed in accordance with the NHS Standard Contract general terms.
These are controlled documents, whilst these documents may be printed; the electronic versions posted on the CCG’s website is the controlled copy. Any printed copies of these documents are not controlled. As controlled documents, these policies should not be saved onto local network drives but should always be accessed from the Intranet.
If you need help accessing a document it is available on request in other formats (for example large print, easy read, Braille or audio versions) and languages. Please call the Communications & Engagement Team on 01332 868730 or email firstname.lastname@example.org.
Derby and Derbyshire Clinical Commissioning Group’s aim is to design and implement policy documents that meet the diverse needs of the populations to be served and the NHS workforce has a duty to have regard to the need to reduce health inequalities in access to health services and health outcomes achieved as enshrined in the Health and Social Care Act 2012. are is committed to ensuring equality of access and non-discrimination, irrespective of age, gender, disability (including learning disability), gender reassignment, marriage and civil partnership, pregnancy and maternity, race, religion or belief, sex (gender) or sexual orientation.
It takes into account current UK legislative requirements, including the Equality Act 2010 and the Human Rights Act 1998, and promotes equality of opportunity for all. This document has been designed to ensure that no-one receives less favourable treatment owing to their personal circumstances.
In carrying out their functions, the Clinical Policies Advisory Group on behalf of Derby and Derbyshire CCG are committed to having due regard to the Public Sector Equality Duty. This applies to all the activities for which the CCG is responsible, including policy development and review.
Derbyshire Health Optimisation for Surgical Interventions
Any surgical intervention carries a risk, however small, to the patient. These risks are increased in those who are overweight/ obese, smoke or have poorly controlled long term conditions. When surgery is planned this is a good opportunity to offer support to patients to stop smoking, reduce their weight and optimise treatment of long term conditions in order to reduce their risks and improve their recovery and other outcomes. This could be achieved by referral to an appropriate lifestyle service for help with obesity and smoking and working with healthcare professionals for management of any long term conditions.
Purpose of the Policy
The purpose of the Procedures of Limited Clinical Value (PLCV) policy is to clarify the commissioning intentions NHS Derby and Derbyshire CCG.
The CCG Commissioners only fund treatment for clinically effective interventions that are then delivered to the right patients. It sets out the treatments deemed to be of insufficient priority to justify funding from the available fixed budget.
This policy list a number of procedures and services that the CCG restrict funding for. Patients should only be referred for the procedures and services listed in this policy if they meet the eligibility set out. The onus is on the clinician to seek prior approval from the commissioner by completing a prior approval application. The clinician must provide sufficient information to evidence how the patient meets the criteria.
If a provider undertakes one of the procedures contained within this policy commissioners will not reimburse the provider unless explicit agreement has been given by the CCG, via the Prior Approvals procedure.
Please note; this document does not reference those interventions where the CCG has previously published policy statements setting out restrictions/criteria/prior approval requirements.
This policy supports the decision making process associated with the allocation of resources for commissioning. It will be used to support the development of effective, efficient and ethical NHS Standard Contracts with provider organisations, and the procurement of intentions on an exceptional basis.
The policy establishes the framework within which the CCG can demonstrate that their decision making processes are fair, equitable, ethical and legally sound.
Assessing what the overall population most needs
Our approach to this situation is to prioritise what we spend, so that the local population gets access to the healthcare that is most needed.
This assessment of need is made across the whole population and, wherever possible, on the basis of best evidence about what works. We also aim to do this in a way that is fair, so that different people with equal need have equal opportunity to access services. This approach is not new. It is consistent with other NHS organisations who commission healthcare for their local populations.
One result of this kind of assessment is a list of some of the treatments which can only be paid for by the local NHS in certain restricted circumstances, and also a number of treatments which do not work well enough to justify any use within the local NHS. The Derbyshire policy group aim is to continually to review the list of procedures to ensure the policy reflects the best available evidence and allocation of our resource is fair.
Procedures of Limited Clinical Value and associated treatments are not commissioned by the NHS Commissioners, except where an individual patient satisfies the threshold statement or criteria against a procedure or treatment. Clinicians considering offering a patient a restricted procedure or treatment should satisfy themselves that the threshold statement or criteria against the procedure or treatment are satisfied. Where a patient satisfies the threshold statement or criteria, the procedure or treatment is allocated a prior approval reference, and can be undertaken. Where the threshold statement or criteria are not met, then the procedure or treatment is excluded for that patient.
Procedures of Limited Clinical Value (PLCV) are those which deliver a relatively poor output/outcome to the population. In this policy, the term PLCV has been extended to include procedures which have been identified as being either only marginally effective or ineffective in terms of their clinical impact. There may additional significant differences in value depending on the setting in which the procedure is delivered (usually due to large differences in pricing between providers).
The procedures (PLCV) in this policy are those which:
A number of national and local organisations, such as National Institute for Health and Clinical Excellence (NICE), have developed evidence based advice to inform commissioning decisions on low priority treatments. These treatments or procedures are not usually funded by the NHS. In addition the CCG has responsibility to decide the priorities for commissioning in line with agreed criteria.
Making Commissioning Decisions
Commissioning involves specifying, securing and monitoring services that are evidence- based, cost effective, of high quality and meet individuals ?needs” and provide "value for money in the use of public resources”.
Determining the Evidence Base
Evidence for treatment effectiveness and efficacy is available from many sources, including NICE, Cochrane Institute, Royal Colleges, Professional guidelines, and sources such as peer reviewed journals or technical notes. Evidence varies in its robustness, ranging from meta-analyses of randomised control trials with large populations of participants, to traditional consensus about best practice. The CCG has considered the source, extent and quality of the evidence in reaching their decisions.
In their dealings with patients and the public providers should, if necessary,
make it clear that the decision by NHS Commissioners to consider treatments
or procedures to be of low priority under this policy is a considered decision
made against their responsibility to seek the greatest health advantage possible
for local populations using the resources allocated to them and that it is necessary
for the NHS Commissioners to make decisions regarding the investment of resources
in interventions which achieve the greatest health gain for the local population.
Where individual patient circumstances require the escalation of their care providers should refer to the Policy and Procedure for the Authorisation and Management of Individual Funding Requests,
Ethical and Legal Policy for Decision Making
The CCG has a Decision-Making Framework which is kept under review by the CCG's Governing Body.
The Commissioning Policy for PLCV is set out below and can be incorporated into contractual and service level agreements. NHS Derby and Derbyshire CCG will require primary and secondary care service providers to embrace and abide by the policy and advise patients accordingly.
The policy is implemented by the Primary Care and Secondary Care Health Professionals when advising and referring patients and by providers when considering the treatment options for patients. Those making referrals should not refer to any provider for a treatment or procedure covered by this Policy. Providers should not suggest, recommend or otherwise offer excluded treatments or procedures covered by this Policy to any patient. Providers should only suggest, recommend or otherwise offer restricted treatments or procedures covered by this Policy to patients who satisfy the appropriate threshold statement for that treatment or procedure.
The Schedule of PLCV
The schedule is informed by indicative codes. There may be cases where a code is not included but the procedure is called the same; it should be assumed that the threshold will apply in the same way.
This policy should be read in conjunction with other policies and pathways e.g. East Midlands Commissioning Policy for Cosmetic Procedures 2014, musculoskeletal pathway.
All providers and referrers, secondary care services, primary care services, community care services, associate commissioners.
Monitoring the Policy
NHS Commissioners will monitor the adherence to this policy through the contractual process, using contractual levers where breaches of the Policy are identified.
Maintaining an up-to-date Policy
NHS Derby and Derbyshire CCG will abide by this policy when making decisions relating to the provision of low priority treatments.
Specifically, the role of the CCG is to: